ARDX stock


Ardelyx Inc (ARDX) Hits the Home Run; BTIG Boosts Price Target

Tim Chiang now sees a bigger per share value for ARDX’s tenapanor in the IBS-C market.

Mara Goldstein Sees 80% Upside for Ardelyx Inc (ARDX) Following Clinical Trial Victory

Ardelyx’s drug tenapanor gets closer to FDA approval; Cantor’s Mara Goldstein weighs in.

Analysts Dig Into Three Volatile Biotech Stocks: AcelRx Pharmaceuticals Inc (ACRX), Ardelyx Inc (ARDX), and Trevena Inc (TRVN)

Analysts are cautious to sure-fire confident on mover and shakers sending the Street into a frenzy today.

Mara Goldstein Bullish on Ardelyx Inc (ARDX) as IBS-C Trial Delivers Positive Results

Tenapanor is a viable drug in the treatment of IBS-C, says Cantor’s Mara Goldstein.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts